Ortho evra and Rhinitis - a phase IV clinical study of FDA data
Summary:
Rhinitis is reported as a side effect among people who take Ortho evra (ethinyl estradiol; norelgestromin), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Cipro,.
The phase IV clinical study analyzes which people have Rhinitis when taking Ortho evra. It is created by eHealthMe based on reports of 29,122 people who have side effects when taking Ortho evra from the FDA, and is updated regularly.
What is Ortho evra?
Ortho evra has active ingredients of ethinyl estradiol; norelgestromin. It is often used in birth control. eHealthMe is studying from 29,275 Ortho evra users. Check the latest studies of Ortho evra.
What is Rhinitis?
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose) is found to be associated with 979 drugs and 968 conditions by eHealthMe. Check the latest studies of Rhinitis.
29,122 people reported to have side effects when taking Ortho evra.
Among them, 15 people (0.05%) have Rhinitis.

Among these 15 people:
How long have people been on Ortho evra when they have Rhinitis? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Rhinitis when taking Ortho evra? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Rhinitis when taking Ortho evra? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 30.77 %
- 20-29: 30.77 %
- 30-39: 30.77 %
- 40-49: 7.69 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Ortho evra? *
- Zyrtec: 1 person, 6.67%
- Prednisone: 1 person, 6.67%
- Nasonex: 1 person, 6.67%
- Motrin: 1 person, 6.67%
- Metronidazole: 1 person, 6.67%
- Maxair: 1 person, 6.67%
- Imuran: 1 person, 6.67%
- Flovent: 1 person, 6.67%
- Cyclosporine: 1 person, 6.67%
- Cipro: 1 person, 6.67%
What are other side effects people have besides Rhinitis? *
- Headache (pain in head): 4 people, 26.67%
- Vaginal Bleeding Between Periods: 3 people, 20.00%
- Nausea (feeling of having an urge to vomit): 3 people, 20.00%
- Cough: 2 people, 13.33%
- Dizziness: 2 people, 13.33%
- Dyspnea (difficult or laboured breathing): 1 person, 6.67%
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 1 person, 6.67%
- Breast Pain: 1 person, 6.67%
- Chills (felling of cold): 1 person, 6.67%
- Fever: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Ortho evra and have Rhinitis?
- Check whether Rhinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ortho evra:
- Ortho evra (29,275 reports)
Rhinitis treatments and more:
- Rhinitis (15,448 reports)
How severe was Rhinitis and when was it recovered:
Expand to all the drugs that have ingredients of ethinyl estradiol; norelgestromin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ortho evra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Rhinitis:
- Rhinitis (979 drugs)
Browse all the conditions that are associated with Rhinitis:
- Rhinitis (968 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ethinyl estradiol; norelgestromin (the active ingredients of Ortho evra) and Ortho evra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Warfarin Sodium cause Prostate Cancer Metastatic? - 2 seconds ago
- Drug interactions of Lactulose and Vigabatrin - 7 seconds ago
- Drug interactions of Sulfamethoxazole And Trimethoprim and Desyrel - 8 seconds ago
- Drug interactions of Melatonin and Mupirocin - 9 seconds ago
- Could Prozac cause Blood Testosterone Decreased? - 11 seconds ago
- Could Diprivan cause Skin Discoloration? - 13 seconds ago
- Drug interactions of Detrol La and Vesicare - 15 seconds ago
- Drug interactions of Cordran and Detrol - 37 seconds ago
- Pain In Extremity and Convulsion - 47 seconds ago
- Could Ondansetron cause Abnormal Loss Of Weight? - 48 seconds ago